Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 43547-421

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 43547-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 12.5 30.jpg.jpg

FDA Label Image

20 12.5 30.jpg.jpg

FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 20/25 mg (100 tablets)

Lisinopril And Hydrochlorothiazide Tablets  20/25 mg (100 tablets)
Lisinopril and (L IO T T (T TEPAT) Tablets, USP are medicines which need to be stored at a controlled temperature ranging from 20°C to 25°C and protected from excessive heat and the reach of children. Dosage guidance needs to be followed as per the accompanying prescription. These tablets are packaged in a 25, light-resistant container with a Canressort closure. The manufacturer is Zeiangtiana Pramscentica Co, L1 with distribution handled by SokcoHeamaie US, LLC based in Somerset, NJ 08873 USA. The text also includes a reference to wnocassar42240 R only and a notation that a box is FPO to indicate the area to be left uncoated, however, it is unclear from the text what these refer to.*
FDA Label Image

Structural Formula 1 (Image 01)

FDA Label Image

Structural Formula 2 (Image 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.